Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.

BMC Health Services Research
Constance StegbauerFreimut Schliess

Abstract

Type 2 diabetes represents an increasingly critical challenge for health policy worldwide. It absorbs massive resources from both patients and national economies to sustain direct costs of the treatment of type 2 diabetes and its complications and indirect costs related to work loss and wages. More recently, there are innovations based on remote control and personalised programs that promise a more cost-effective diabetes management while reducing diabetes-related complications. In such a context, this work attempts to update cost analysis reviews on type 2 diabetes, focusing on France and Germany, in order to explore most significant cost drivers and cost-saving opportunities through innovations in diabetes care. Although both countries approach care delivery differently, France and Germany represent the primary European markets for diabetes technologies. A systematic review of the literature listed in MEDLINE, Embase and EconLit has been carried out. It covered interventional, observational and modelling studies on expenditures for type 2 diabetes management in France or Germany published since 2012. Included articles were analysed for annual direct, associated and indirect costs of type 2 diabetes patients. An appraisal of s...Continue Reading

References

Feb 12, 2004·PharmacoEconomics·Lorraine EttaroMichael M Engelgau
Jun 3, 2004·Annals of Internal Medicine·Ping ZhangK M Venkat Narayan
Jul 6, 2006·BMC Health Services Research·Jeroen N StruijsGeertrudis A M van den Bos
Nov 30, 2006·PLoS Medicine·Colin D Mathers, Dejan Loncar
Dec 20, 2007·Diabetes/metabolism Research and Reviews·Brian M Frier
Aug 22, 2008·Diabetes Technology & Therapeutics·Irl B HirschBruce A Buckingham
Jan 7, 2009·Health Affairs·Sandra L DeckerJane E Sisk
Oct 19, 2011·Diabetes Research and Clinical Practice·A DrabikS Stock
Jan 13, 2012·Diabetes Care·Crystal M Smith-SpanglerJeremy D Goldhaber-Fiebert
Apr 10, 2013·La Presse médicale·Céline DruetAnne Fagot-Campagna
Mar 13, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·D T SittigJ Wasem
Aug 26, 2014·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·A LieblA J Palmer
Oct 8, 2014·Nature Reviews. Endocrinology·Brian M Frier
Mar 18, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·N MüllerU A Müller
Mar 20, 2015·PharmacoEconomics·Till SeuringMarc Suhrcke
Sep 29, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·C SortsøM Emneus
Jul 13, 2016·Journal of Diabetes Science and Technology·Louis JacobKarel Kostev
Feb 16, 2017·Diabetic Medicine : a Journal of the British Diabetic Association·E JacobsW Rathmann
Sep 1, 2017·Applied Health Economics and Health Policy·Lili WangKristy Sanderson
Jan 3, 2018·BMC Health Services Research·Rebecca JohnsonAileen Clarke
Sep 23, 2018·Journal of Diabetes Science and Technology·Freimut SchliessLutz Heinemann
Jan 7, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·François-Olivier BaudotAnne Fagot-Campagna
Jan 22, 2019·Journal of Diabetes Science and Technology·Andrew A Bremer, Guillermo Arreaza-Rubín

❮ Previous
Next ❯

Citations

Feb 18, 2021·Medicine·Kuixu LanJunfang Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
amputations
amputation

Software Mentioned

excel
Statbureau
EconLit

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.